Please sign in with your existing account details.
Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.
Privacy statement - Terms and conditions
Forgotten your password?
You have exceeded the maximum number of login attempts for this email address and your account has been locked. An email has been sent to member of Browne Jacobson's web team and some one will be contacting you over the next two working days with details of how to change your password.
Are you sure you want to remove this item from you pinned content?
The Government has confronted studies showing English adults trailing behind the rest of the world in literacy and maths studies by introducing their latest policy: a mathematics overhaul through the creation of a "core mathematics" qualification enabling more pupils to study the subject from 16-18.
Currently only one fifth of pupils study maths post 16 and poor performance is largely linked to lower investment in colleges and universities for this age range. The DfE have responded by spending £20 million from 2014 - 2016 in supporting schools and colleges in developing teaching for this new course.
The changes seek to provide young people with the numeracy skills they need to compete in a global economy, promote social mobility and subsequently increase the number of young people in employment. However, will the government's educational reform be sufficient to restore confidence in the exam system and provide the springboard for England to catch up, both in the league tables, and, with the rest of the world.
With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.
View blog
The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.
Our top tips for supporting transgender and non-binary pupils.
On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.
Select which mailings you would like to receive from us.
Sign up